Randomized Controlled Trials — Design and Analysis

Statistics

The Gold Standard for Establishing Causation

RCTs eliminate confounding through random assignment, ensuring treatment groups are comparable in expectation. Proper design — blinding, power analysis, intention-to-treat — maximizes the credibility of causal conclusions.

Drug Development — Establish pharmaceutical efficacy for regulatory approval
Technology — Test feature impact through A/B testing on user populations
Education — Evaluate curriculum changes with randomized classroom assignments

Randomization is the great equalizer — it balances known and unknown confounders simultaneously.

A randomized controlled trial (RCT) is the gold standard for establishing causal relationships because randomization ensures that treatment and control groups are comparable in expectation.

DfRandomized Controlled Trial

An experimental design where units are randomly assigned to treatment or control conditions, allowing causal effects to be estimated without confounding.

Key Components of an RCT

| Component | Description |

|-----------|------------|

| Randomization | Random assignment to treatment/control |

| Control group | Receives placebo or standard treatment |

| Blinding | Participants/researchers unaware of assignment |

| Sample size | Determined by power analysis |

| Pre-registration | Specify analysis plan before data collection |

Why Randomization Works

Balance Through Randomization

Randomization ensures that all confounders (observed and unobserved) are, in expectation, equally distributed across groups:

E[X|T=1] = E[X|T=0]

This eliminates selection bias and allows clean causal identification.

Treatment Effects in RCTs

ATE in RCTs

\text{ATE} = E[Y_i(1) - Y_i(0)] = E[Y|T=1] - E[Y|T=0]

Here,

$E[Y|T=1]$ =Mean outcome in treatment group
$E[Y|T=0]$ =Mean outcome in control group

With randomization, the naive comparison identifies the ATE.

Sample Size and Power

Sample Size for Two Means

n = \frac{(z_{\alpha/2} + z_{\beta})^2 \cdot 2\sigma^2}{\delta^2}

Here,

$\alpha$ =Significance level (typically 0.05)
$\beta$ =Type II error rate (power = 1 - ß)
$\sigma$ =Standard deviation of outcome
$\delta$ =Minimum detectable effect size

Power Considerations

Higher power (e.g., 0.90) requires larger samples
Smaller effects require larger samples
More variability requires larger samples
Always conduct a power analysis before the trial

Types of Analysis

Intention-to-Treat (ITT)

DfITT Analysis

Analyze participants in the group they were originally assigned to, regardless of whether they actually received the treatment.

| Advantage | Disadvantage |

|-----------|-------------|

| Preserves randomization | May underestimate effect |

| Handles non-compliance | Diluted by non-adherence |

| Clinically relevant | |

Per-Protocol Analysis

Analyze only participants who fully complied with the protocol. May introduce bias if non-compliance is related to outcomes.

Blinding

| Type | Who is blinded | Purpose |

|------|---------------|---------|

| Single-blind | Participants | Reduces placebo effect |

| Double-blind | Participants + researchers | Reduces observer bias |

| Triple-blind | Participants + researchers + analysts | Reduces analysis bias |

Common Pitfalls

Threats to Validity

Attrition: Participants drop out differentially
Contamination: Control group receives treatment
Hawthorne effect: Behavior changes because of observation
Non-compliance: Participants don't follow assigned treatment
Multiple testing: Testing many outcomes inflates false positives

CONSORT Flow

A well-reported RCT follows the CONSORT guidelines:

Enrollment: How many were assessed and randomized?
Allocation: How many assigned to each group?
Follow-up: How many lost to follow-up?
Analysis: How many included in final analysis?

Python Implementation


import numpy as np

import pandas as pd

from scipy import stats

import matplotlib.pyplot as plt



np.random.seed(42)



# Simulate RCT

n = 500

X1 = np.random.randn(n)  # Age

X2 = np.random.binomial(1, 0.5, n)  # Gender



# Randomization

T = np.random.binomial(1, 0.5, n)



# Outcome (true ATE = 3.0)

Y0 = 50 + 0.5*X1 + 2*X2 + np.random.randn(n)*10

Y1 = Y0 + 3.0

Y = T * Y1 + (1 - T) * Y0



df = pd.DataFrame({'Y': Y, 'T': T, 'age': X1, 'gender': X2})



# Check balance (should be balanced due to randomization)

treat = df[df['T']==1]

control = df[df['T']==0]

print("Balance check:")

print(f"Age: treat={treat['age'].mean():.2f}, control={control['age'].mean():.2f}")

print(f"Gender: treat={treat['gender'].mean():.2f}, control={control['gender'].mean():.2f}")



# Two-sample t-test

t_stat, p_val = stats.ttest_ind(treat['Y'], control['Y'])

print(f"\nTreatment effect: {treat['Y'].mean() - control['Y'].mean():.2f}")

print(f"95% CI: [{treat['Y'].mean()-control['Y'].mean()-1.96*10*np.sqrt(2/n):.2f}, "

      f"{treat['Y'].mean()-control['Y'].mean()+1.96*10*np.sqrt(2/n):.2f}]")

print(f"p-value: {p_val:.4f}")



# Power analysis

from statsmodels.stats.power import TTestIndPower

power_analysis = TTestIndPower()

power = power_analysis.power(effect_size=3.0/10, nobs1=250, ratio=1.0, alpha=0.05)

print(f"\nPower: {power:.3f}")

Worked Example

Example: Drug Efficacy Trial

A Phase III trial tests a new blood pressure drug:

|--------|-------------------|-----------------|------------|

| SD | 12.3 | 11.8 | — |

| 95% CI | — | — | [-8.1, -3.3] |

| p-value | — | — | < 0.001 |

ITT analysis: 15 patients in treatment group didn't take medication. The ITT analysis includes them (diluted effect = -5.0).

Per-protocol: Among compliant patients only (effect = -6.8).

Both approaches show significant benefit; per-protocol shows larger effect but may be biased.

Key Takeaways

Summary: RCTs

Randomization is the gold standard for causal inference
It balances all confounders (observed and unobserved) across groups
Conduct a power analysis before the trial to determine sample size
Intention-to-treat analysis is preferred for preserving randomization
Blinding reduces bias (double-blind is ideal)
Follow CONSORT guidelines for transparent reporting
Check balance on baseline characteristics to verify randomization worked

Randomized Controlled Trials — Design and Analysis

Randomized Controlled Trials — Design and Analysis

The Gold Standard for Establishing Causation

DfRandomized Controlled Trial

Key Components of an RCT

Why Randomization Works

Treatment Effects in RCTs

ATE in RCTs

Sample Size and Power

Sample Size for Two Means

Types of Analysis

Intention-to-Treat (ITT)

DfITT Analysis

Per-Protocol Analysis

Blinding

Common Pitfalls

CONSORT Flow

Python Implementation

Worked Example

Example: Drug Efficacy Trial

Key Takeaways

Summary: RCTs

Related Topics

Premium Content

Need Expert Statistics Help?